| 000 | 01286 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250514183016.0 | ||
| 264 | 0 | _c20040517 | |
| 008 | 200405s 0 0 eng d | ||
| 022 | _a1540-0352 | ||
| 024 | 7 |
_a10.3816/cgc.2003.n.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Daniel W | |
| 245 | 0 | 0 |
_aThe role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma. _h[electronic resource] |
| 260 |
_bClinical prostate cancer _cSep 2003 |
||
| 300 |
_a119-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xchemistry |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 | _aCyclooxygenase 2 Inhibitors |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xchemistry |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProstaglandin-Endoperoxide Synthases |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xepidemiology |
| 700 | 1 | _aNelson, Peter S | |
| 773 | 0 |
_tClinical prostate cancer _gvol. 2 _gno. 2 _gp. 119-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/cgc.2003.n.020 _zAvailable from publisher's website |
| 999 |
_c14758043 _d14758043 |
||